Tag | Content |
---|
EnhancerAtlas ID | HS023-15612 |
Organism | Homo sapiens |
Tissue/cell | CD8+ |
Coordinate | chr2:235231270-235232640 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
ELF1 | MA0473.2 | chr2:235232532-235232544 | CACTTCCGGTTT | - | 6.27 | ELF4 | MA0641.1 | chr2:235232532-235232544 | CACTTCCGGTTT | - | 6.27 | ELK1 | MA0028.2 | chr2:235232532-235232542 | CACTTCCGGT | - | 6.02 | ERG | MA0474.2 | chr2:235232532-235232542 | CACTTCCGGT | - | 6.02 | ETS1 | MA0098.3 | chr2:235232532-235232542 | CACTTCCGGT | - | 6.02 | FEV | MA0156.2 | chr2:235232532-235232542 | CACTTCCGGT | - | 6.02 | FLI1 | MA0475.2 | chr2:235232532-235232542 | CACTTCCGGT | - | 6.02 |
|
| Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
SE_17518 | chr2:235230984-235233139 | CD4p_CD25-_CD45RAp_Naive |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH02I234323 | chr2 | 235231865 | 235232186 |
|
Enhancer Sequence | GATTTGCTTT AAAATTTTTT AAAATGTAGA CTAGGGCAAT GTGAGACAAG ATTTTTTAAA 60 TGGTGATAAT CATTGAAGCT GAAACGGGTA ATGGGCACAT TGATGTATTA TAGTTTTTAA 120 TTTTGGGGTA TGTTTGAAAT TTTCTGAAAA AGAAAAAAGT AATAATACAA CTGGCTGCAG 180 TTATGAAAAT AAAAGTAAAT CAATATCAGG ATAATCTTGG GTCTCAGTGT GTTAATTCAG 240 GATAATTCAA GATTTTACTG ACACTGAAAC ATTAGATTTA GTGGATTCTT TTTCTCTGTC 300 AACATTACTG TTCGTGATGT TGTTTCATGC GTCAGATGCT AGGGACATAT TTTCAGTGTT 360 TATACTGGGA AATGCTAAAA TTTTCTTGAC TTCCTTTTTA TGAATCAAGT TGTTTATCAC 420 TAATTGCTCT TTAACTGCCT GTTCAATACA TTAAGATCAA GAATCTCTAA CTCCTATTTA 480 ATTCTAAAGG AATTTTCAGT GATATAAGAA ATAAAGAAGC ATAGGAGGAT TAAAGACTTA 540 AAAATTCAGA GATTATGCAA AATGAACAAA GAAAGCTCAC ATTTCCAGGT AGCACTGAGA 600 AAGTGTCTTG GAAACAGGAT ACCATATTTG TTTCTGAGTT TCCTGGTAAC CAAGGCTAAA 660 AGCAAAACAC AGATGATACC CAGAAAGTAA AATCAGACAC ATTAACCTGC ATTCATAATA 720 AAACTACACT TCTGATGAAA TACATCTCTA ATGATTATTC TTGGATATGG AGTAGCACTA 780 ATATCACCTT CACTTGCTGT TTTATATAAG ACATAGGGAT GCCATGTAAA TAAAAGCTTA 840 CCGAATTCAT TCTCTATGAA GCTTAAAAAT ACATTGTTAA TTATAAATCA GTAGCATTGG 900 CTCCATGGAA AGTTAAAAAA ATATGGTCCA GGCATTTTGT TTTCTGAAGA TCTAAGTAAA 960 GTGAATAATA TCAAAGAATG GTCAAGCCAT GTGTCCTTAG TTAGTCTGTC TGGCACCTCC 1020 AGGATTTGGT GAAACCTGGG CAGGGGCTGG AGAAGCAGAG TTGCCCTCTC TCCCAGACTC 1080 TCTTATGCCC ACACTGACCA TTGATCCCCC CACTGTACTT TGGGAAGACA CCAATTCTGT 1140 TAGACCTTCC CAGGGACCTT ACCAAAAAGG TTTCAAAGTC AAGTACTGAG ATGTGATGGT 1200 CTGAACAGTG TTACACCAGT TTTCTTTTTC TTTTTCTTTT TTCTTATTTT TTTGCTGCAG 1260 GACACTTCCG GTTTTGAACA CACCAGGTTT TAATTTGAAT GTGTGAGAGG CGTAGAGTGT 1320 ACGATTTCTC CAGTTTGGTT GACCACGGAA TCCCTCTTTC TCCCCTGCTT 1370
|